BeOne Medicines
ONC
#590
Rank
A$59.91 B
Marketcap
A$526.61
Share price
-0.33%
Change (1 day)
10.00%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$8.75

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$8.50. In 2025 the company made an earnings per share (EPS) of A$3.88 an increase over its 2024 EPS that were of A-$8.87.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$8.75125.52%
2025A$3.88-143.75%
2024A-$8.87
2022A-$27.7328.21%
2021A-$21.63-19.96%
2020A-$27.0220.81%
2019A-$22.3731.52%
2018A-$17.01417.57%
2017A-$3.29-37.16%
2016A-$5.23158.95%
2015A-$2.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.35-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA